Endologix, Inc. (ELGX) Posts Q3 EPS Loss of $0.09, Raises FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Marketing and sales: 26.01M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Marketing and sales: 26.01M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Endologix, Inc. (NASDAQ: ELGX) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $22.3 million versus the consensus estimate of $20.14 million.
Endologix, Inc. sees FY2011 EPS of $-0.30-$-0.25. Endologix, Inc. sees FY2011 revenue of $82-$84 million, versus prior guidance of $79-$82 million.
Endologix, Inc. sees FY2011 EPS of $-0.30-$-0.25. Endologix, Inc. sees FY2011 revenue of $82-$84 million, versus prior guidance of $79-$82 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
- Mannatech (MTEX) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
